Darko Butina has extensive experience and an impressive track-record in drug discovery and research strategy. After a first degree in Engineering and Chemistry at the University of Zagreb, Darko went on gain a Ph.D in synthetic organic chemistry in the US before joining UCL (London) as a post-doctoral fellow. Darko joined Glaxo in 1979, where he developed critical areas of the company’s drug development capabilities and was one of the team who invented Sumatriptan, a GSK blockbuster and one of the worlds most important anti-migraine drugs. Darko has been promoted to several senior roles in drug discovery, later becoming Director of Computational Chemistry and Chemoinformatics at ArQule, where he was a leading member of the company’s international development team. Darko has extensive project development experience, has strong technical and commercial links in the discovery field and extensive publications. Darko brings experience, creativity, a pragmatic approach, vision and high-level problem solving skills to drug discovery and is able to communicate across diverse skills groups including medicinal chemistry, programming, analysis and biology.